Purchase Order 75F40119P10576
- Not listed
- This is a $76,649.53 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Elsevier B.V., a global information analytics company, for annual online access to reference modules, ebooks, and journals in the biomedical sciences. The contract was awarded as a sole-source requirement with no set-aside designation. The contract provides the FDA Library with enterprise-wide access to Elsevier's platforms, such as ScienceDirect, Scopus, Reaxys, and Embase, which contain...
- This is a federal contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Elsevier B.V., doing business as North-Holland (Publishing), a global information analytics company. The contract, valued at $3,202,226.57, is for ScienceDirect online subscription services. It is a definitive, firm-fixed-price contract with no set-aside designation. The contract has an ultimate completion date of December 31, 2018 and was awarded on December 31, 2015. Elsevier B.V. has received...
- This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Elsevier B.V., a subsidiary of Reed International PLC, to provide a subscription to the EMBASE.COM research database. The contract has a ceiling value of $225,758.00 and a period of performance from January 13, 2014 to January 13, 2019. Elsevier is a global information analytics company that specializes in scientific, technical, and medical content publishing. This contract does not have a...
- This federal contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Elsevier B.V., doing business as North-Holland (Publishing), a global information analytics company. The $302,641.04 firm-fixed-price purchase order is for IT and telecommunications web-based subscription services. The contract has a completion date of March 29, 2023 and was originally awarded on April 13, 2018. Elsevier, as the prime contractor, specializes in providing...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Elsevier Inc., a leading global provider of scientific, technical, and medical information products and services. The contract, valued at $107,500.00, is for the provision of FAERS SOFTWARE - EMBASE, a proprietary medical research platform, over a 4-year period from May 2024 to April 2028. Elsevier holds two significant federal Indefinite Delivery Vehicles (IDVs) with the Library of Congress and the...
- This is a federal contract awarded by the Office of the Director, a civilian agency, to Elsevier B.V., doing business as North-Holland (Publishing), a for-profit organization. The contract, valued at $1,892,963.54, is for the delivery of online access to ScienceDirect, Reaxys, Scopus, and Embase databases through December 2024. These databases provide scholarly literature, patents, and chemical substance information to support biomedical, engineering, and scientific research initiatives across...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order for an ELSEVIER EMBASE SUBSCRIPTION to Elsevier B.V., doing business as North-Holland (Publishing), a global information analytics company. The contract has a potential value of $224,747.00 and provides the FDA with online access to Elsevier's Embase database, which contains scientific literature, patents, and other research publications to support biomedical and...
- This is a $329,662.56 firm-fixed-price definitive contract awarded by the Federal Trade Commission (FTC) to Elsevier B.V., doing business as North-Holland (Publishing), for a subscription to the ScienceDirect online database. The contract has a period of performance through December 31, 2029. Elsevier B.V. is a global information analytics company that provides scientific, technical, and medical content, including journals, books, and databases, to government agencies and other organizations....
- This is a $24,542 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Elsevier B.V., doing business as North-Holland (Publishing). The contract is for a one-year enterprise-wide license renewal for unlimited user access to Elsevier's scientific, technical, and medical content platforms, including ScienceDirect, Scopus, Reaxys, and Embase. This contract is not...
- This federal contract award, valued at $92,661.43, was issued by the Office of Research and Development (ORD) to Elsevier B.V., doing business as North-Holland (Publishing), for an annual subscription to the Scopus database. The contract is a firm-fixed-price purchase order and does not have a set-aside designation. Elsevier B.V. is a global information analytics company and a subsidiary of Reed International PLC. The company has received over $60 million in prime federal contracts, primarily...
This is a $82,421.32 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Elsevier B.V., a global information analytics company and subsidiary of Reed International PLC. The contract is for perpetual and annual licenses/access to Elsevier's eBooks and subscriptions to support the FDA's research initiatives. The award has no set-aside designation. Elsevier B.V. has received over $60 million in prime federal contracts, primarily from civilian agencies like the Department of Health and Human Services, National Aeronautics and Space Administration, and Department of Commerce, to provide access to its scholarly literature, patent, and chemical substance databases such as ScienceDirect, Scopus, Reaxys, and Embase. The company also holds significant indefinite delivery contracts with the National Institutes of Health and Library of Congress to supply online research services and publishing services to federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $82.4k | 8/29/19 |